Victoria S. Benson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Victoria S. Benson has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Jane Green
Cancer Epidemiology Unit, University of Oxford, UK
3 shared publicationsJohn A. VanLeeuwen
Department of Health Management, Atlantic Veterinary College (V.S.B., J.A.V.), Department of Family & Nutritional Sciences (J.T.), University of Prince Edward Island, Water Management Division, Department of Environment, Energy and Forestry (G.S.S.), Department of Health and Social Services (L.V.T.), Charlottetown, PE, CANADA, Paediatric Epidemiology Group, Centre for Epidemiology and Biostatistics (P.A.M.) University of Leeds, Leeds, ENGLAND
3 shared publicationsKirstin Pirie
Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF, UK and International Agency for Research on Cancer (IARC), Section of Environment and Radiation, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France
3 shared publicationsValerie Beral
Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF, UK and International Agency for Research on Cancer (IARC), Section of Environment and Radiation, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France
3 shared publicationsfor the Million Women Study Collaborators
3 shared publicationsGillian K Reeves
Cancer Epidemiology Unit, University of Oxford, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF, UK and International Agency for Research on Cancer (IARC), Section of Environment and Radiation, 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France
2 shared publications
Latest Publications
- Open Access
- 27 September 2013
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 43 (1) , 275
Authors' response to: the case of acoustic neuroma: comment on mobile phone use and risk of brain neoplasms and other cancers.
We thank Dr de Vocht for his interest in our report on the risk of cancer and other conditions in mobile phone users.1 In that report, follow-up for cancer was up to 2009, but we have since received updated follow-up data to 2011. We have repeated the analyses published in our report and the new results are shown in Table 1. There is no longer a significant association between long duration of use of a mobile phone and acoustic neuroma risk: the relative risk for 10+ years vs never use is now 1.17 (95% confidence interval 0.60–2.27; based on 14 vs 43 cases). There is also no significant trend in risk with duration of use (P = 0.3).
- 27 September 2013
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 43 (1) , 275
Open AccessAuthors' response to: the case of acoustic neuroma: comment on mobile phone use and risk of brain neoplasms and other cancers.
We thank Dr de Vocht for his interest in our report on the risk of cancer and other conditions in mobile phone users.1 In that report, follow-up for cancer was up to 2009, but we have since received updated follow-up data to 2011. We have repeated the analyses published in our report and the new results are shown in Table 1. There is no longer a significant association between long duration of use of a mobile phone and acoustic neuroma risk: the relative risk for 10+ years vs never use is now 1.17 (95% confidence interval 0.60–2.27; based on 14 vs 43 cases). There is also no significant trend in risk with duration of use (P = 0.3).
- Open Access
- 8 May 2013
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 42 (3) , 792-802
Mobile phone use and risk of brain neoplasms and other cancers: prospective study
Background Results from some retrospective studies suggest a possible increased risk of glioma and acoustic neuroma in users of mobile phones. Methods The relation between mobile phone use and incidence of intracranial central nervous system (CNS) tumours and other cancers was examined in 791 710 middle-aged women in a UK prospective cohort, the Million Women Study. Cox regression models were used to estimate adjusted relative risks (RRs) and 95% confidence intervals (CIs). Women reported mobile phone use in 1999 to 2005 and again in 2009. Results During 7 years’ follow-up, 51 680 incident invasive cancers and 1 261 incident intracranial CNS tumours occurred. Risk among ever vs never users of mobile phones was not increased for all intracranial CNS tumours (RR = 1.01, 95% CI = 0.90–1.14, P = 0.82), for specified CNS tumour types nor for cancer at 18 other specified sites. For long-term users compared with never users, there was no appreciable association for glioma (10+ years: RR = 0.78, 95% CI = 0.55–1.10, P = 0.16) or meningioma (10+ years: RR = 1.10, 95% CI = 0.66–1.84, P = 0.71). For acoustic neuroma, there was an increase in risk with long term use vs never use (10+ years: RR = 2.46, 95% CI = 1.07–5.64, P = 0.03), the risk increasing with duration of use (trend among users, P = 0.03). Conclusions In this large prospective study, mobile phone use was not associated with increased incidence of glioma, meningioma or non-CNS cancers.
- 8 May 2013
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 42 (3) , 792-802
Open AccessMobile phone use and risk of brain neoplasms and other cancers: prospective study
Background Results from some retrospective studies suggest a possible increased risk of glioma and acoustic neuroma in users of mobile phones. Methods The relation between mobile phone use and incidence of intracranial central nervous system (CNS) tumours and other cancers was examined in 791 710 middle-aged women in a UK prospective cohort, the Million Women Study. Cox regression models were used to estimate adjusted relative risks (RRs) and 95% confidence intervals (CIs). Women reported mobile phone use in 1999 to 2005 and again in 2009. Results During 7 years’ follow-up, 51 680 incident invasive cancers and 1 261 incident intracranial CNS tumours occurred. Risk among ever vs never users of mobile phones was not increased for all intracranial CNS tumours (RR = 1.01, 95% CI = 0.90–1.14, P = 0.82), for specified CNS tumour types nor for cancer at 18 other specified sites. For long-term users compared with never users, there was no appreciable association for glioma (10+ years: RR = 0.78, 95% CI = 0.55–1.10, P = 0.16) or meningioma (10+ years: RR = 1.10, 95% CI = 0.66–1.84, P = 0.71). For acoustic neuroma, there was an increase in risk with long term use vs never use (10+ years: RR = 2.46, 95% CI = 1.07–5.64, P = 0.03), the risk increasing with duration of use (trend among users, P = 0.03). Conclusions In this large prospective study, mobile phone use was not associated with increased incidence of glioma, meningioma or non-CNS cancers.
- Open Access
- 22 August 2012
- Published by The Royal Society in Biology Letters
- Vol. 8 (6) , 1040-1041
The relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas et al .
Thomas et al. recently compared national statistics on the prevalence of antibodies to T. gondii infection (seroprevalence ranging from 4% to 67%) with incidence of brain cancer. After adjustment for gross domestic product, sex, mobile phone use and latitude, they found that there was a correlation between the prevalence of antibodies to T. gondii and the incidence of brain cancer [7]. They estimated that there was a 1.8-fold increase in brain cancer incidence in countries with the highest prevalence of T. gondii antibodies, compared with countries with the lowest prevalence.
- 22 August 2012
- Published by The Royal Society in Biology Letters
- Vol. 8 (6) , 1040-1041
Open AccessThe relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas et al .
Thomas et al. recently compared national statistics on the prevalence of antibodies to T. gondii infection (seroprevalence ranging from 4% to 67%) with incidence of brain cancer. After adjustment for gross domestic product, sex, mobile phone use and latitude, they found that there was a correlation between the prevalence of antibodies to T. gondii and the incidence of brain cancer [7]. They estimated that there was a 1.8-fold increase in brain cancer incidence in countries with the highest prevalence of T. gondii antibodies, compared with countries with the lowest prevalence.
- Open Access
- 25 July 2011
- Published by Wiley in International Journal of Cancer
- Vol. 130 (12) , 2961-2973
Toward standardizing and reporting colorectal cancer screening indicators on an international level: The international colorectal cancer screening network
The International Colorectal Cancer Screening Network was established in 2003 to promote best practice in the delivery of organized colorectal cancer screening programs. To facilitate evaluation of such programs, we defined a set of universally applicable colorectal cancer screening measures and indicators. To test the feasibility of data collection, we requested data on these variables and basic program characteristics from 26 organized full programs and 9 pilot programs in 24 countries. The size of the target population for each program varied considerably from a few thousand to 36 million. The majority of programs used fecal occult blood tests for primary screening, with more using guaiac than immunochemical tests. There was wide variation in the ability of screening programs to report the requested measures and in the values reported. In general, pilot programs were more likely to provide screening measure values than were full programs. As expected, detection rates for polyps and neoplasia were substantially higher in programs screening with endoscopy than in those using fecal occult blood tests. It is hoped that the screening measures and indicators, once revised in the light of this survey, will be adopted and used by existing programs and those in the early planning stages, allowing international comparison with the goal of improved colorectal cancer screening quality.
- 25 July 2011
- Published by Wiley in International Journal of Cancer
- Vol. 130 (12) , 2961-2973
Open AccessToward standardizing and reporting colorectal cancer screening indicators on an international level: The international colorectal cancer screening network
The International Colorectal Cancer Screening Network was established in 2003 to promote best practice in the delivery of organized colorectal cancer screening programs. To facilitate evaluation of such programs, we defined a set of universally applicable colorectal cancer screening measures and indicators. To test the feasibility of data collection, we requested data on these variables and basic program characteristics from 26 organized full programs and 9 pilot programs in 24 countries. The size of the target population for each program varied considerably from a few thousand to 36 million. The majority of programs used fecal occult blood tests for primary screening, with more using guaiac than immunochemical tests. There was wide variation in the ability of screening programs to report the requested measures and in the values reported. In general, pilot programs were more likely to provide screening measure values than were full programs. As expected, detection rates for polyps and neoplasia were substantially higher in programs screening with endoscopy than in those using fecal occult blood tests. It is hoped that the screening measures and indicators, once revised in the light of this survey, will be adopted and used by existing programs and those in the early planning stages, allowing international comparison with the goal of improved colorectal cancer screening quality.
- 1 December 2010
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 29 (6) , 612-624
Type 1 Diabetes Mellitus and Components in Drinking Water and Diet: A Population-Based, Case-Control Study in Prince Edward Island, Canada
Objective: To determine the relationship between the risk of type 1 diabetes (T1D) and daily intake of drinking water and dietary components, including nitrate, nitrite, and nitrosamines, during the year prior to diagnosis. Methods: Controls (n = 105) were matched by age at diagnosis and sex to T1D cases (n = 57) newly diagnosed during 2001–2004. Food consumption was assessed using a food frequency questionnaire. Locally available samples of foods were tested for nitrate, nitrite, and nitrosamine concentrations. Water consumption was determined through an additional questionnaire, and water samples were taken from homes and tested for routine chemical components, including nitrate. Results: After controlling for age, age, sex, and daily energy intake, nitrate intake from food sources showed a non‐significant positive trend (odds ratios and 95% confidence intervals for quartiles = 1.00, 1.63 (0.58, 4.63), 1.71 (0.54, 5.40), 3.02 (0.78, 11.74); p for trend = 0.13). Nitrite and nitrosamine intake were not related to T1D risk (p for trend = 0.77 and 0.81, respectively). When food and water components were combined, zinc and calcium intakes were marginally and inversely related to T1D risk (p for trend = 0.07 and 0.06, respectively). After further model adjustment of possible confounders and significant risk factors, an increased intake of caffeine marginally increased the risk of T1D (p = 0.07). Conclusion: Dietary components from both food and water sources may influence the risk of developing T1D in young persons.
- 1 December 2010
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 29 (6) , 612-624
Type 1 Diabetes Mellitus and Components in Drinking Water and Diet: A Population-Based, Case-Control Study in Prince Edward Island, Canada
Objective: To determine the relationship between the risk of type 1 diabetes (T1D) and daily intake of drinking water and dietary components, including nitrate, nitrite, and nitrosamines, during the year prior to diagnosis. Methods: Controls (n = 105) were matched by age at diagnosis and sex to T1D cases (n = 57) newly diagnosed during 2001–2004. Food consumption was assessed using a food frequency questionnaire. Locally available samples of foods were tested for nitrate, nitrite, and nitrosamine concentrations. Water consumption was determined through an additional questionnaire, and water samples were taken from homes and tested for routine chemical components, including nitrate. Results: After controlling for age, age, sex, and daily energy intake, nitrate intake from food sources showed a non‐significant positive trend (odds ratios and 95% confidence intervals for quartiles = 1.00, 1.63 (0.58, 4.63), 1.71 (0.54, 5.40), 3.02 (0.78, 11.74); p for trend = 0.13). Nitrite and nitrosamine intake were not related to T1D risk (p for trend = 0.77 and 0.81, respectively). When food and water components were combined, zinc and calcium intakes were marginally and inversely related to T1D risk (p for trend = 0.07 and 0.06, respectively). After further model adjustment of possible confounders and significant risk factors, an increased intake of caffeine marginally increased the risk of T1D (p = 0.07). Conclusion: Dietary components from both food and water sources may influence the risk of developing T1D in young persons.
- Open Access
- 4 August 2010
- Published by Wiley in International Journal of Cancer
- Vol. 127 (7) , 1692-1698
Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study
We examined the relation between the use of hormone replacement therapy (HRT) and the incidence of central nervous system (CNS) tumours in a large prospective study of 1,147,894 postmenopausal women. Women were aged 56.6 years on average at entry, and HRT use was recorded at recruitment and updated, where possible, about 3 years later. During a mean follow‐up of 5.3 years per woman, 1,266 CNS tumours were diagnosed, including 557 gliomas, 311 meningiomas and 117 acoustic neuromas. Compared with never users of HRT, the relative risks (RRs) for all incident CNS tumours, gliomas, meningiomas and acoustic neuromas in current users of HRT were 1.20 (95% CI: 1.05–1.36), 1.09 (95% CI: 0.89–1.32), 1.34 (95% CI: 1.03–1.75) and 1.58 (95% CI: 1.02–2.45), respectively, and there was no significant difference in the relative risks by tumour type (heterogeneity p = 0.2). In past users of HRT the relative risk was 1.07 (95% CI: 0.93–1.24) for all CNS tumours. Among current users of HRT, there was significant heterogeneity by the type of HRT with the users of oestrogen‐only HRT at higher risk of all CNS tumours than users of oestrogen–progestagen HRT (RR = 1.42, 95% CI: 1.21–1.67 versus RR = 0.97, 95% CI: 0.82–1.16) (heterogeneity p < 0.001). Among current users of oestrogen‐only and oestrogen–progestagen HRT, there was no significant heterogeneity by duration of use, hormonal constituent or mode of administration of HRT.
- 4 August 2010
- Published by Wiley in International Journal of Cancer
- Vol. 127 (7) , 1692-1698
Open AccessHormone replacement therapy and incidence of central nervous system tumours in the Million Women Study
We examined the relation between the use of hormone replacement therapy (HRT) and the incidence of central nervous system (CNS) tumours in a large prospective study of 1,147,894 postmenopausal women. Women were aged 56.6 years on average at entry, and HRT use was recorded at recruitment and updated, where possible, about 3 years later. During a mean follow‐up of 5.3 years per woman, 1,266 CNS tumours were diagnosed, including 557 gliomas, 311 meningiomas and 117 acoustic neuromas. Compared with never users of HRT, the relative risks (RRs) for all incident CNS tumours, gliomas, meningiomas and acoustic neuromas in current users of HRT were 1.20 (95% CI: 1.05–1.36), 1.09 (95% CI: 0.89–1.32), 1.34 (95% CI: 1.03–1.75) and 1.58 (95% CI: 1.02–2.45), respectively, and there was no significant difference in the relative risks by tumour type (heterogeneity p = 0.2). In past users of HRT the relative risk was 1.07 (95% CI: 0.93–1.24) for all CNS tumours. Among current users of HRT, there was significant heterogeneity by the type of HRT with the users of oestrogen‐only HRT at higher risk of all CNS tumours than users of oestrogen–progestagen HRT (RR = 1.42, 95% CI: 1.21–1.67 versus RR = 0.97, 95% CI: 0.82–1.16) (heterogeneity p < 0.001). Among current users of oestrogen‐only and oestrogen–progestagen HRT, there was no significant heterogeneity by duration of use, hormonal constituent or mode of administration of HRT.
- Open Access
- 17 June 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (1) , 185-190
Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort
Previous studies have reported inconsistent results on the effect of anthropometric and lifestyle factors on the risk of developing glioma or meningioma tumours. A prospective cohort of 1.3 million middle-aged women was used to examine these relationships. During 7.7 million women-years of follow-up, a total of 1563 women were diagnosed with a primary incident central nervous system tumour: 646 tumours were classified as glioma and 390 as meningioma. Our results show that height is related to the incidence of all central nervous system tumours with a risk of about 20% per 10 cm increase in height (relative risk=1.19, 95% CI=1.10–1.30 per 10 cm increase in height, P−2 increase in BMI (relative risk=1.17, 95% CI=1.03–1.34 per 10 kg m−2 increase in BMI, P=0.02). Smoking status, alcohol intake, socioeconomic level, parity, age at first birth, and oral contraceptive use were not associated with the risk of glioma or meningioma tumours. In conclusion, for women in the United Kingdom, the incidence of glioma or meningioma tumours increases with increasing height and increasing BMI.
- 17 June 2008
- Published by Springer Nature in British Journal of Cancer
- Vol. 99 (1) , 185-190
Open AccessLifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort
Previous studies have reported inconsistent results on the effect of anthropometric and lifestyle factors on the risk of developing glioma or meningioma tumours. A prospective cohort of 1.3 million middle-aged women was used to examine these relationships. During 7.7 million women-years of follow-up, a total of 1563 women were diagnosed with a primary incident central nervous system tumour: 646 tumours were classified as glioma and 390 as meningioma. Our results show that height is related to the incidence of all central nervous system tumours with a risk of about 20% per 10 cm increase in height (relative risk=1.19, 95% CI=1.10–1.30 per 10 cm increase in height, P−2 increase in BMI (relative risk=1.17, 95% CI=1.03–1.34 per 10 kg m−2 increase in BMI, P=0.02). Smoking status, alcohol intake, socioeconomic level, parity, age at first birth, and oral contraceptive use were not associated with the risk of glioma or meningioma tumours. In conclusion, for women in the United Kingdom, the incidence of glioma or meningioma tumours increases with increasing height and increasing BMI.
- 1 June 2008
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 27 (3) , 414-420
Food Consumption and the Risk of Type 1 Diabetes in Children and Youth: A Population-Based, Case-Control Study in Prince Edward Island, Canada
Objective: The objective of this study was to determine if the consumption of certain foods during the year prior to diagnosis of type 1 diabetes mellitus (T1D) was associated with the risk of developing T1D in children and youth residing in Prince Edward Island, Canada. Methods: Cases (n = 57) consisted of newly diagnosed patients with T1D during 2001 to 2004. Controls (n = 105) were randomly selected from the province's population, and matched to cases by age at diagnosis and sex. Food consumption in cases and controls was assessed using two previously validated food frequency questionnaires, and a survey was developed to collect information on potential environmental and genetic risk factors. Results: The median age at diagnosis was nine years, and 67% of cases were male. After controlling for the matched variables and four significant environmental and genetic risk factors (family members with T1D, the number of infections during the first two years of life, place of residence, and father's education) in the final logistic regression model, the consumption of regular soft drinks (OR = 2.78, 95% CI = 1.21, 6.36) and eggs (OR = 2.50, 95% CI = 1.09, 5.75) were significant risk factors of T1D, when consumed once per week or more often. Conclusion: Diet may play a role in the development of T1D. However, further research is needed to confirm these observed associations.
- 1 June 2008
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 27 (3) , 414-420
Food Consumption and the Risk of Type 1 Diabetes in Children and Youth: A Population-Based, Case-Control Study in Prince Edward Island, Canada
Objective: The objective of this study was to determine if the consumption of certain foods during the year prior to diagnosis of type 1 diabetes mellitus (T1D) was associated with the risk of developing T1D in children and youth residing in Prince Edward Island, Canada. Methods: Cases (n = 57) consisted of newly diagnosed patients with T1D during 2001 to 2004. Controls (n = 105) were randomly selected from the province's population, and matched to cases by age at diagnosis and sex. Food consumption in cases and controls was assessed using two previously validated food frequency questionnaires, and a survey was developed to collect information on potential environmental and genetic risk factors. Results: The median age at diagnosis was nine years, and 67% of cases were male. After controlling for the matched variables and four significant environmental and genetic risk factors (family members with T1D, the number of infections during the first two years of life, place of residence, and father's education) in the final logistic regression model, the consumption of regular soft drinks (OR = 2.78, 95% CI = 1.21, 6.36) and eggs (OR = 2.50, 95% CI = 1.09, 5.75) were significant risk factors of T1D, when consumed once per week or more often. Conclusion: Diet may play a role in the development of T1D. However, further research is needed to confirm these observed associations.
- 19 January 2007
- Published by Springer Nature in Hydrogeology Journal
- Vol. 15 (5) , 1009-1019
Temporal analysis of groundwater nitrate concentrations from wells in Prince Edward Island, Canada: application of a linear mixed effects model
- 19 January 2007
- Published by Springer Nature in Hydrogeology Journal
- Vol. 15 (5) , 1009-1019
Temporal analysis of groundwater nitrate concentrations from wells in Prince Edward Island, Canada: application of a linear mixed effects model